Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Pharmacotherapy
|
September 1, 1996
The pharmacologic effects of recombinant, human colony-stimulating factors and their modulation by theophylline
W P Petros, G L Rosner, J Rabinowitz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia
W E Evans, J H Rodman, M V Relling, et al.
European Journal of Haematology
|
November 1, 1995
Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy
A M Hussein, M Ross, J Vredenburgh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 1, 1997
The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support
J J Vredenburgh, O Silva, G Broadwater, et al.
European Journal of Haematology
|
May 1, 1995
Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy
A M Hussein, M Ross, J Vredenburgh, et al.
Bone Marrow Transplantation
|
March 7, 1998
Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver
D C Fisher, J J Vredenburgh, W P Petros, et al.
Bone Marrow Transplantation
|
May 7, 1999
Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease
J J Perry, R A Fleming, M V Rocco, et al.
Cytokine
|
July 1, 1995
Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study
L Cartee, W P Petros, G L Rosner, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 1998
Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer
C J Gilbert, W P Petros, J Vredenburgh, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 5, 2000
Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
K S Bhalla, S W Wilczynski, A M Abushamaa, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Pharmacotherapy
|
September 1, 1996
The pharmacologic effects of recombinant, human colony-stimulating factors and their modulation by theophylline
W P Petros, G L Rosner, J Rabinowitz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia
W E Evans, J H Rodman, M V Relling, et al.
European Journal of Haematology
|
November 1, 1995
Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy
A M Hussein, M Ross, J Vredenburgh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 1, 1997
The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support
J J Vredenburgh, O Silva, G Broadwater, et al.
European Journal of Haematology
|
May 1, 1995
Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy
A M Hussein, M Ross, J Vredenburgh, et al.
Bone Marrow Transplantation
|
March 7, 1998
Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver
D C Fisher, J J Vredenburgh, W P Petros, et al.
Bone Marrow Transplantation
|
May 7, 1999
Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease
J J Perry, R A Fleming, M V Rocco, et al.
Cytokine
|
July 1, 1995
Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study
L Cartee, W P Petros, G L Rosner, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 1998
Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer
C J Gilbert, W P Petros, J Vredenburgh, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 5, 2000
Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
K S Bhalla, S W Wilczynski, A M Abushamaa, et al.
Page
of 5